Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc > No insider selling

<< Previous

Bullboard Posts

Next >>

Comment by sovy888on Jul 25, 2018 8:24pm

121 Views

Post# 28368088

RE:RE:RE:RE:No insider selling

okay guys now stop with the nonsense please. The CEO is not a stock trader, what the heck makes you think that he is shorting his own company stock??? why in the earth would he do that huh? would you do it in his position risking the fact to leak, oh let me guess you would do it don't you, you would do it because you're greedy fcuks

<< Previous

Bullboard Posts

Next >>

Who, why, and what of the great "Crypto Surge"